Reaction Details Report a problem with these data
Target
CREB-binding protein [1081-1197]
Ligand
BDBM511322
Substrate
n/a
Meas. Tech.
CBP AlphaScreen Assay
IC50
1.000±n/a nM
Citation
Le, K; Soth, MJ; Jones, P; Cross, JB; Carroll, CL; McAfoos, TJ; Mandal, PK Imidazopiperazine inhibitors of transcription activating proteins US Patent US11058688 Publication Date 7/13/2021
More Info.:
Target
Name:
CREB-binding protein [1081-1197]
Synonyms:
CBP | CBP_HUMAN | CREB-binding protein (CBP)(1081-1197) | CREBBP
Type:
Enzyme Catalytic Domain
Mol. Mass.:
13987.94
Organism:
Homo sapiens (Human)
Description:
Q92793[1081-1197]
Residue:
117
Sequence:
RKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG
Inhibitor
Name:
BDBM511322
Synonyms:
3-Cyclopropyl-N-methyl-1-(3-(2-methylthiazol-5-yl)isoquinolin-8-yl)-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxamide | US11058688, Example 23
Type:
Small organic molecule
Emp. Form.:
C24H24N6OS
Mol. Mass.:
444.552
SMILES:
CNC(=O)N1CCn2c(C1)c(nc2C1CC1)-c1cccc2cc(ncc12)-c1cnc(C)s1